C4 Therapeutics Inc.

1.51
0.07 (5.23%)
At close: Apr 02, 2025, 3:59 PM
1.51
-0.07%
After-hours: Apr 02, 2025, 05:22 PM EDT

C4 Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue 35.58M 20.76M 31.1M 45.78M 33.2M 21.38M 19.36M
Cost of Revenue n/a 117.71M 7.57M 2.91M 77.47M 47.66M 28.59M
Gross Profit 35.58M -96.95M 23.52M 42.88M -44.27M -26.28M -9.23M
Operating Income -119.61M -139.03M -129.53M -82.13M -60.45M -35.45M -16.39M
Interest Income 14.43M 9.81M 3.58M 387K 393K 1.83M 685K
Pretax Income -105.19M -131.21M -128.18M -83.89M -66.96M -33.3M -15.71M
Net Income -105.32M -132.49M -126.5M -86.04M -66.33M -34.1M -15.71M
Selling & General & Admin 42.12M 42.08M 42.79M 33.25M 15.2M 8.77M 7.16M
Research & Development 110.64M 117.71M 117.84M 94.67M 78.44M 48.06M 28.59M
Other Expenses 2.44M n/a n/a n/a n/a 325K -7K
Operating Expenses 155.2M 159.79M 160.63M 127.92M 93.64M 56.83M 35.75M
Interest Expense n/a 1.37M 2.22M 2.15M 1.23M n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 155.2M 159.79M 160.63M 127.92M 93.64M 56.83M 35.75M
Income Tax 131K 1.28M -1.68M 2.15M -626K 804K 678K
Shares Outstanding (Basic) 69.37M 49.64M 48.86M 46.04M 43.06M 42.99M 14.79M
Shares Outstanding (Diluted) 69.37M 49.64M 48.86M 46.04M 43.06M 42.99M 42.09M
EPS (Basic) -1.52 -2.67 -2.59 -1.87 -1.54 -0.79 -1.06
EPS (Diluted) -1.52 -2.67 -2.59 -1.87 -1.54 -0.79 -1.06
EBITDA -103.37M -122.1M -124.28M -78.84M -62.89M -30.56M -15.12M
EBIT -105.19M -129.84M -125.96M -81.75M -65.73M -33.3M -16.39M
Depreciation & Amortization 1.82M 7.74M 7.57M 2.91M 2.84M 2.74M 3.57M